| Aarey Drugs & Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524412 |
NSE Symbol : AAREYDRUGS |
P/E(TTM) : 56.95 |
|
ISIN Demat : INE198H01019 |
Div & Yield% : 0.00 |
EPS(TTM) : 1.21 |
|
Book Value(₹) : 51.13 |
Market Cap(₹Cr) : 195.39 |
Face Value(₹) : 10.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 96.43 | 84.16 | 102.21 | 108.10 | 133.79 | 105.14 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 96.43 | 84.16 | 102.21 | 108.10 | 133.79 | 105.14 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 4.18 | 0.79 | 1.55 | 7.54 | 0.68 | 0.02 |
| Total Income | 100.61 | 84.95 | 103.76 | 115.64 | 134.47 | 105.16 |
| Total Expenditure | 97.94 | 81.52 | 100.51 | 112.30 | 131.59 | 101.42 |
| PBIDT | 2.67 | 3.44 | 3.25 | 3.33 | 2.88 | 3.74 |
| Interest | 0.92 | 1.26 | 1.04 | 1.30 | 0.58 | 0.49 |
| PBDT | 1.75 | 2.17 | 2.22 | 2.03 | 2.30 | 3.25 |
| Depreciation | 0.83 | 0.69 | 0.49 | 0.41 | 0.90 | 1.51 |
| Tax | 0.37 | 0.35 | 0.35 | 1.11 | 0.30 | 0.40 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.02 | 0.11 | 0.01 | 0.05 | 0.38 | -0.25 |
| Reported Profit After Tax | 0.57 | 1.02 | 1.37 | 0.47 | 0.72 | 1.60 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.57 | 1.02 | 1.37 | 0.47 | 0.72 | 1.60 |
| EPS (Unit Curr.) | 0.20 | 0.36 | 0.48 | 0.17 | 0.26 | 0.57 |
| EPS (Adj) (Unit Curr.) | 0.20 | 0.36 | 0.48 | 0.17 | 0.26 | 0.57 |
| Calculated EPS (Unit Curr.) | 0.20 | 0.36 | 0.49 | 0.17 | 0.26 | 0.57 |
| Calculated EPS (Adj) (Unit Curr.) | 0.20 | 0.36 | 0.49 | 0.17 | 0.26 | 0.57 |
| Calculated EPS (Ann.) (Unit Curr.) | 0.80 | 1.44 | 1.96 | 0.67 | 1.02 | 2.28 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.80 | 1.44 | 1.96 | 0.67 | 1.02 | 2.28 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 28.45 | 28.45 | 28.05 | 28.05 | 28.05 | 28.05 |
| Reserve & Surplus | 0.00 | 116.63 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 2.77 | 4.09 | 3.18 | 3.08 | 2.15 | 3.56 |
| PBDTM(%) | 1.81 | 2.58 | 2.17 | 1.88 | 1.72 | 3.09 |
| PATM(%) | 0.59 | 1.21 | 1.34 | 0.43 | 0.54 | 1.52 |
